Essity Study Site
Mölndal, SE40503, Sweden
NCT Number: NCT06248255
The clinical study aims to measure the changes in the stratum corneum on older healthy participants due to the application of a wet pad on the forearm. Participants are subject to baseline measures of TransEpidermalWaterLoss (TEWL), skin hydration (SH), pH and water profile (raman spectroscopy). Dry or wet pads are then added to the skin and worn for two hours. After a recovery period, the SkinSurfaceWaterLoss (SSWL) and skin hydration and water profile is measured. The study is conducted over a single visit. Pads on the arms consist of incontinence product cutouts and are loaded to 50% or 100% capacity. The endpoints are the changes in stratum corneum as measured by the instruments during the visit.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Mölndal, SE40503, Sweden
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single arm design in which each participant act as its own control. Wet or Dry pads are applied to the participants forearms.
Time frame: 2 hours
As measured by Dermalab instrument. Transepidermal water loss (TEWL) from dry skin and the subsequent skin surface water loss (SSWL) from wet skin
Time frame: 2 hours
Skin hydration (SH) as measured with moisturemeter instrument
Time frame: 2 hours
As measured Confocal raman microspectometry. The water content of skin at different depths.
Time frame: 2 hours
Skin surface pH measurement using pH meter
Essity Hygiene and Health AB
Industry
Impact to Skin Due to Wet Pad Application. Skin Status and Change in the Stratum Corneum as Measured With 4 Instruments in an Elderly Population.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06206512
Cardiovascular Diseases, Female Urogenital Diseases
Dallas, Texas, United States
View Trial DetailsNCT06470620
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Haifa, Haifa District, Israel
View Trial DetailsNCT04491617
Agnosia, Incontinence
Cleveland, Ohio, United States
View Trial DetailsNCT05960734
Cancer, Incontinence
Oviedo, Principality of Asturias, Spain
View Trial Details